Literature DB >> 690242

Serum total lipids, lipoprotein cholesterol, and apolipoprotein A in acute viral hepatitis and chronic liver disease.

C Vergani, G Trovato, A Delù, M Pietrogrande, N Dioguardi.   

Abstract

Serum total lipids, lipoprotein cholesterol, apolipoprotein A (Apo A), and liver function tests have been investigated in patients with acute viral hepatitis and chronic liver disease. Hypertriglyceridaemia, absence of alpha and pre beta bands on the lipoprotein electrophoresis pattern, low level of Apo A, and presence of abnormal lipoproteins (beta-VLDL and beta2-LP) were observed in the early phase of acute hepatitis. A positive correlation was found between Apo A and high-density lipoprotein cholesterol, and a negative one between Apo A and triglyceride, bile acids, total bilirubin, and serum alanine aminotransferase. Lipoprotein abnormalities found in the early phase of acute hepatitis are probably due to low lecithin-cholesterol acyltransferase activity. The reappearance of alpha lipoprotein and the increase of Apo A are sensitive indices of improvement of liver function. In chronic liver disease low levels of cholesterol and Apo A indicate the severity of liver cell injury.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 690242      PMCID: PMC1145405          DOI: 10.1136/jcp.31.8.772

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  26 in total

1.  Lecithin:cholesterol acyltransferase and plasma proteins in liver diseases.

Authors:  J P Blomhoff; S Skrede; S Ritland
Journal:  Clin Chim Acta       Date:  1974-06-19       Impact factor: 3.786

2.  Hypertriglyceridaemia secondary to liver disease.

Authors:  P Müller; R Felin; J Lambrecht; B Agostini; H Wieland; W Rost; D Seidel
Journal:  Eur J Clin Invest       Date:  1974-12-05       Impact factor: 4.686

Review 3.  Synthesis and secretion of plasma lipoproteins.

Authors:  R L Hamilton
Journal:  Adv Exp Med Biol       Date:  1972       Impact factor: 2.622

4.  Rate of in vitro incorporation of precursors into hepatic lipids and proteins in patients with extrahepatic cholestasis.

Authors:  H Stakeberg; H Lundborg; T Scherstén
Journal:  Eur J Clin Invest       Date:  1974-12-05       Impact factor: 4.686

5.  Electrophoretic separation of plasma lipoproteins in agarose gel.

Authors:  R P Noble
Journal:  J Lipid Res       Date:  1968-11       Impact factor: 5.922

6.  A classification of chronic hepatitis.

Authors:  J De Groote; V J Desmet; P Gedigk; G Korb; H Popper; H Poulsen; P J Scheuer; M Schmid; H Thaler; E Uehlinger
Journal:  Lancet       Date:  1968-09-14       Impact factor: 79.321

7.  Plasma lecithin: cholesterol acyltransferase activity in acute hepatitis.

Authors:  E Gjone; J P Blomhoff; I Wiencke
Journal:  Scand J Gastroenterol       Date:  1971       Impact factor: 2.423

8.  [A new determination of the neutral fats in blood serum and tissue. I. Principles, procedure, and discussion of the method].

Authors:  M Eggstein; F H Kreutz
Journal:  Klin Wochenschr       Date:  1966-03-01

9.  Abnormal plasma lipoproteins and lecithin-cholesterol acyltransferase deficiency in alcoholic liver disease.

Authors:  S M Sabesin; H L Hawkins; L Kuiken; J B Ragland
Journal:  Gastroenterology       Date:  1977-03       Impact factor: 22.682

10.  A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects.

Authors:  D Seidel; P Alaupovic; R H Furman
Journal:  J Clin Invest       Date:  1969-07       Impact factor: 14.808

View more
  6 in total

1.  Impaired plasma lipid profiles in acute hepatitis.

Authors:  Libo Luo; Xiangke Pu; Yongzhong Wang; Ning Xu
Journal:  Lipids Health Dis       Date:  2010-01-23       Impact factor: 3.876

2.  Low plasma apolipoprotein A-I level is not a reliable marker of fibrosis in children with chronic hepatitis B.

Authors:  Mukadder-Ayse Selimoglu; Rasit-Vural Yagcl; Gül Yüce
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

3.  Hepatitis B virus-mediated changes of apolipoprotein mRNA abundance in cultured hepatoma cells.

Authors:  Pamela A Norton; Qiaoke Gong; Anand S Mehta; Xuanyong Lu; Timothy M Block
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 4.  Theoretical basis of a beneficial role for vitamin D in viral hepatitis.

Authors:  Khanh vinh quốc Lương; Lan Thi Hoàng Nguyễn
Journal:  World J Gastroenterol       Date:  2012-10-14       Impact factor: 5.742

5.  Alterations of lipid metabolism in Wilson disease.

Authors:  Jessica Seessle; Annina Gohdes; Daniel Nils Gotthardt; Jan Pfeiffenberger; Nicola Eckert; Wolfgang Stremmel; Ulrike Reuner; Karl Heinz Weiss
Journal:  Lipids Health Dis       Date:  2011-05-19       Impact factor: 3.876

6.  Metabolic Dysregulation in Hepacivirus Infection of Common Marmosets (Callithrix jacchus).

Authors:  Cordelia Manickam; Lynn Wachtman; Amanda J Martinot; Luis D Giavedoni; R Keith Reeves
Journal:  PLoS One       Date:  2017-01-13       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.